Given that chromosomal rearrangements and copy number variations are infrequent in the region flanking the A3B locus as well as a lack of promoter demethylation at adjacent CpG islands, and thus the observed upregulation of A3B in breast cancers is presumably due to upstream signal transduction12. Here, APOBEC3B is linked to breast cancer.